Phorbol myristate acetate-induced Egr-1 expression is suppressed by phospholipase D isozymes in human glioma cells

FEBS Letters

Volumn 581, Issue 30, 2007, Pages 5940-5944

  Ahn, Bong Hyun ^a   Park, Mi Hee ^b   Lee, Young Han ^c   Min, Do Sik ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Pusan National University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Egr 1; Glioma; Phospholipse D; PI3K; PMA

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; EARLY GROWTH RESPONSE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE D; SP 60125; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; EARLY GROWTH RESPONSE PROTEIN 1; GENES, REPORTER; GLIOMA; HUMANS; ISOENZYMES; PHOSPHOLIPASE D; RESPONSE ELEMENTS; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS);

EID: 37049028810     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.077     Document Type: Article

References (17)

1. Liu C., Rangnekar V.M., Adamson E., and Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 5 (1998) 3-28
2. Bauer I., Hohl M., Al-Sarraj A., Vinson C., and Thiel G. Transcriptional activation of the Egr-1 gene mediated by tetradecanoylphorbol acetate and extracellular signal-regulated protein kinase. Arch. Biochem. Biophys. 438 (2005) 36-52
3. Muthukkumar S., Nair P., Sells S.F., Maddiwar N.G., Jacob R.J., and Rangnekar V.M. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol. Cell. Biol. 15 (1995) 6262-6272
4. Huang R.P., Fan Y., de Belle I., Niemeyer C., Gottardis M.M., Mercola D., and Adamson E.D. Decreased EGR-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int. J. Cancer 72 (1997) 102-109
5. Levin W.J., Press M.F., Gaynor R.B., Sukhatme V.P., Boone T.C., and Slamon D.J. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11 (1995) 1261-1269
6. Calogero A., Arcella A., Gregorio G.D., Porcellini A., Mercola D., Liu C., Lombari V., Zani M., Giannini G., Gagliardi F.M., Caruso R., and Ragona G. The early growth response gene EGR-1 behaves as suppressor gene that is down-regulated independently of ARF/MDM2 but not p53 alternations in fresh human gliomas. Clin. Cancer Res. 7 (2001) 2788-2796
7. Huang R.P., Darland T., Okamura D., Mercola D., and Adamson E.D. Suppression of v-sis-dependent transformation by the transcription factor, EGR-1. Oncogene 9 (1994) 1367-1377
8. Foster D.A., and Xu L. Phospholipase D in cell proliferation and cancer. Mol. Cancer Res. 1 (2003) 789-800
9. Kim J., Lee Y.H., Kwon T.K., Chang J.S., Chung K.C., and Min D.S. Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10. Cancer Res. 66 (2006) 784-793
10. Prados M.D., and Levin V. Biology and treatment of malignant glioma. Semin. Oncol. 27 (2000) 1-10
11. Min D.S., Ahn B.H., Rhie D.J., Yoon S.H., Hahn S.J., Kim M.S., and Jo Y.H. Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells. Neuropharmacology 41 (2001) 384-391
12. Calogero A., Arcella A., Gregorio G.D., Porcellini A., Mercola D., Liu C., Lombari V., Zani M., Giannini G., Gagliardi F.M., Caruso R., and Ragona G. The early growth response gene EGR-1 behaves as suppressor gene that is down-regulated independently of ARF/MDM2 but not p53 alternations in fresh human gliomas. Cli. Cancer Res. 7 (2001) 2788-2796
13. Baek S.J., Wilson L.C., His L.C., and Eling T.E. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. J. Biol. Chem. 278 (2003) 5845-5853
14. Franzen P., Ichijo H., and Miyazono K. Different signals mediate transforming growth factor-beta-1-induced growth inhibition and extracellular matrix production in prostate carcinoma cells. Exp. Cell Res. 207 (1993) 1-7
15. Nair P., Muthukkumar S., Sell S.F., Han S.S., Sukhatme V.P., and Rangnekar V.M. Early growth response-1-dependent apoptosis is mediated by p53. J. Biol. Chem. 272 (1997) 20131-20138
16. Virolle T., Adamson E.D., Baron D., Mercola D., Mustelin T., and de Belle I. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3 (2001) 1124-1128
17. Baek S.J., Kim J.S., Moore S.M., Lee S.H., Martinez J., and Eling T.E. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol. Pharmacol. 67 (2005) 356-364